Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. lowered its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 15.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 30,108 shares of the company’s stock after selling 5,527 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Doximity were worth $1,607,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in DOCS. Handelsbanken Fonder AB raised its stake in Doximity by 0.7% during the 4th quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company’s stock valued at $1,586,000 after acquiring an additional 200 shares in the last quarter. UMB Bank n.a. raised its stake in Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after acquiring an additional 235 shares in the last quarter. GAMMA Investing LLC raised its stake in Doximity by 20.6% during the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company’s stock valued at $93,000 after acquiring an additional 296 shares in the last quarter. MetLife Investment Management LLC raised its stake in Doximity by 0.6% during the 3rd quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock valued at $2,835,000 after acquiring an additional 363 shares in the last quarter. Finally, State of Alaska Department of Revenue raised its stake in Doximity by 2.6% during the 4th quarter. State of Alaska Department of Revenue now owns 14,610 shares of the company’s stock valued at $780,000 after acquiring an additional 370 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Insider Activity

In other news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 37.40% of the stock is currently owned by corporate insiders.

Doximity Stock Down 3.2 %

Shares of NASDAQ DOCS opened at $68.22 on Tuesday. The stock has a market capitalization of $12.74 billion, a price-to-earnings ratio of 68.22, a PEG ratio of 4.10 and a beta of 1.39. The stock’s fifty day simple moving average is $62.11 and its 200 day simple moving average is $50.95. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $85.21.

Analysts Set New Price Targets

DOCS has been the topic of several recent analyst reports. Truist Financial lifted their target price on Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a research note on Thursday, November 14th. Barclays boosted their price objective on Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a research note on Monday, November 11th. Bank of America boosted their price objective on Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research note on Monday, January 6th. Canaccord Genuity Group boosted their price objective on Doximity from $60.00 to $71.00 and gave the stock a “hold” rating in a research note on Friday, February 7th. Finally, Raymond James reissued an “outperform” rating and issued a $83.00 price objective (up previously from $65.00) on shares of Doximity in a research note on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $64.22.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.